Insider · CIK 0001587074

Trieu Vuong

CIK 0001587074 Name as filed on the most recent filing

Filed as Trieu Vuong (21)

30 transaction lines · from 21 filings · filed 2017-02-08 to 2026-07-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

30 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-07-01 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 10,344, acquired Open Form 4 filing 0001493152-26-031846
2026-06-24 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 5,175, acquired Open Form 4 filing 0001493152-26-029997
2026-06-23 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 3,375, acquired Open Form 4 filing 0001493152-26-029997
2026-06-22 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 2,925, acquired Open Form 4 filing 0001493152-26-029997
2026-06-17 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 10,693, acquired Open Form 4 filing 0001493152-26-029137
2026-06-15 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 4,320, acquired Open Form 4 filing 0001493152-26-029137
2025-07-10 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 520, acquired Open Form 4 filing 0001641172-25-018620
2025-07-09 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 0.00, acquired Open Form 4 filing 0001641172-25-018620
2025-07-08 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 474, acquired Open Form 4 filing 0001641172-25-018620
2025-01-31 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 1,786, acquired Open Form 4 filing 0001493152-25-004486
2025-01-30 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 2,800, acquired Open Form 4 filing 0001493152-25-004486
2025-01-29 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 5,126, acquired Open Form 4 filing 0001493152-25-004486
2024-11-22 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 8,627, acquired Open Form 4 filing 0001493152-24-047762
2024-08-23 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 10,000, acquired Open Form 4 filing 0001493152-24-033939
2023-06-29 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 8,925, acquired Open Form 4 filing 0001493152-23-023015
2023-06-28 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 1,950, acquired Open Form 4 filing 0001493152-23-023015
2023-06-16 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 2,600, acquired Open Form 4 filing 0001493152-23-021800
2023-06-14 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 13,040, acquired Open Form 4 filing 0001493152-23-021563
2023-05-26 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 4,327, acquired Open Form 4 filing 0001493152-23-019557
2023-05-02 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 4,500, acquired Open Form 4 filing 0001493152-23-015195
2022-12-06 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 6,000, acquired Open Form 4 filing 0001493152-22-034663
2022-11-22 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 5,600, acquired Open Form 4 filing 0001493152-22-033681
2022-09-26 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 1,360, acquired Open Form 4 filing 0001493152-22-026963
2022-08-25 P, Open-market purchase Oncotelic Therapeutics, Inc.OTLC 6,560, acquired Open Form 4 filing 0001493152-22-024234
2020-11-19 P, Open-market purchase Mateon Therapeutics IncMATN 9,595, acquired Open Form 4 filing 0001493152-20-022256
2020-03-26 P, Open-market purchase Mateon Therapeutics IncMATN 360, acquired Open Form 4 filing 0001415889-20-000880
2017-06-09 P, Open-market purchase Marina Biotech, Inc.MRNA 3,900, acquired Open Form 4 filing 0001493152-17-006494
2017-06-08 P, Open-market purchase Marina Biotech, Inc.MRNA 7,800, acquired Open Form 4 filing 0001493152-17-006346
2017-06-07 P, Open-market purchase Marina Biotech, Inc.MRNA 950, acquired Open Form 4 filing 0001493152-17-006346
2017-02-06 P, Open-market purchase Marina Biotech, Inc.MRNA 250,000, acquired Open Form 4 filing 0001493152-17-001242

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 30
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Trieu Vuong, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001587074

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.